16 Results for "

SGLT2-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "SGLT2-IN-1" in MCE Product Catalog:

Cat. No.: HY-I1120
CAS No.: 864070-37-1
Target:  

SGLT

Research Areas:  

Metabolic Disease

SGLT2-IN-1 (Compound 5) is an inhibitor for sodium-dependent glucose cotransporter (SGLT2), with IC50 of 33 nM in CHO cells transfected with human SGLT2. SGLT2-IN-1 is selective for SGLT2 over SGLT1. SGLT2-IN-1 is an active metabolite of dapagliflozinactive metabolite of dapagliflozin .
loading...
    loading...
97
97 Cited Publications
Cat. No.: HY-15409
CAS No.: 864070-44-0
Purity:  99.90%
Synonyms: BI 10773
Target:  

SGLT

Research Areas:  

Infection Metabolic Disease Cancer

Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2 .
loading...
    loading...
Cat. No.: HY-109144
CAS No.: 1415472-28-4
Purity:  98.43%
Synonyms: DWP-16001
Target:  

SGLT

Research Areas:  

Metabolic Disease

Enavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor .
loading...
    loading...
Cat. No.: HY-15409R
CAS No.: 864070-44-0
Synonyms: BI 10773 (Standard)
Research Areas:  

Metabolic Disease

Empagliflozin (Standard) is the analytical standard of Empagliflozin. This product is intended for research and analytical applications. Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2 .
loading...
    loading...
Cat. No.: HY-174400
SGLT2-IN-2 (Compound E9) is an inhibitor of SGLT2. SGLT2-IN-2 significantly enhances the inhibition of SGLT2, NHE1, and SOD enzyme activity. SGLT2-IN-2 has protective effect on the glucose-free DMEM-induced injured cardiomyocytes. SGLT2-IN-2 significantly improves cardiac function in TAC-induced HF mice and inhibits cardiomyocyte hypertrophy as well as collagen deposition. SGLT2-IN-2 can ameliorate myocardial tissue damage and enhance mitochondrial autophagy in injured cardiomyocytes, thereby increasing survival rates in HF mice .
loading...
    loading...
Cat. No.: HY-10450S
CAS No.: 1204219-80-6
Purity:  98.01%
Synonyms: BMS-512148-d5
Dapagliflozin-d5 is a deuterium labeled Dapagliflozin (HY-10450). Dapagliflozin is a competitive SGLT2 inhibitor .
loading...
    loading...
Cat. No.: HY-10451S
CAS No.: 1997338-61-0
Purity:  99.04%
Synonyms: JNJ 28431754-d4
Canagliflozin-d4 (JNJ 28431754-d4) is a deuterium labeled Canagliflozin. Canagliflozin is a selective SGLT2 inhibitor .
loading...
    loading...
Cat. No.: HY-15409S
CAS No.: 2749293-95-4
Purity:  97.64%
Synonyms: BI 10773-d4
Empagliflozin-d4 is deuterium labeled Empagliflozin. Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2 .
loading...
    loading...
Cat. No.: HY-I1120R
CAS No.: 864070-37-1
Research Areas:  

Metabolic Disease

SGLT2-IN-1 (standard) is the analytical standard for SGLT2-IN-1. This product is used for research and analytical applications. SGLT2-IN-1 (Compound 5) is an inhibitor for sodium-dependent glucose cotransporter (SGLT2), with IC50 of 33 nM in CHO cells transfected with human SGLT2. SGLT2-IN-1 is selective for SGLT2 over SGLT1. SGLT2-IN-1 is an active metabolite of dapagliflozinactive metabolite of dapagliflozin.
loading...
    loading...
Cat. No.: HY-109092A
CAS No.: 2730989-98-5
Synonyms: rel-LIK066
Target:  

SGLT

rel-Licogliflozin is a relative configuration of Licogliflozin (HY-109092). Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor .
loading...
    loading...
Cat. No.: HY-15409S1
Synonyms: BI 10773-13C6
Empagliflozin- 13C6 (BI 10773- 13C6) is 13C labeled Empagliflozin. Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2 .
loading...
    loading...
Cat. No.: HY-15409S2
Synonyms: BI 10773-d6
Empagliflozin-d6 (BI 10773-d6) is deuterium labeled Empagliflozin. Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2 .
loading...
    loading...
Cat. No.: HY-166652S
CAS No.: 2714418-84-3
Empagliflozin-d8 is the deuterium labeled Empagliflozin. Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2 .
loading...
    loading...
Cat. No.: HY-109144R
CAS No.: 1415472-28-4
Synonyms: DWP-16001 (Standard)
Research Areas:  

Metabolic Disease

Enavogliflozin (Standard) is the analytical standard of Enavogliflozin (HY-109144). This product is intended for research and analytical applications. Enavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor .
loading...
    loading...
Cat. No.: HY-180527
Research Areas:  

Metabolic Disease

SGLT2-IN-5 (Compound 99) is an orally active SGLT2 inhibitor with IC₅₀ values for SGLT2, SGLT1, and DPP4 of 0.8, 23, and 58 nM respectively. SGLT2-IN-5 controls blood sugar levels in diabetic rat models and increases the levels of active GLP-1. SGLT2-IN-5 can be used for the study of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-180528
Research Areas:  

Metabolic Disease

SGLT2-IN-6 (Compound 101) is an orally active SGLT2 inhibitor with IC₅₀ values for SGLT2, SGLT1, and DPP4 of 0.8, 6.7, and 72 nM respectively. SGLT2-IN-6 controls blood sugar levels in diabetic rat models and increases the levels of active GLP-1. SGLT2-IN-6 can be used for the study of type 2 diabetes .
loading...
    loading...
  • 1